Bokf, Na Medi Wound Ltd. Transaction History

Bokf, Na

  • $5.65 Billion
  • Q3 2024

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$1.33 - $2.35 $71,233 - $125,863
-53,559 Closed
0 $0
Q1 2022

May 13, 2022
SELL
$1.86 - $3.24 $584,082 - $1.02 Million
-314,023 Reduced 85.43%
53,559 $107,000
Q4 2021

Mar 11, 2022
BUY
$2.2 - $4.01 $10,076 - $18,365
4,580 Added 1.26%
367,582 $867,000
Q3 2021

Nov 10, 2021
BUY
$3.34 - $4.63 $377,560 - $523,384
113,042 Added 45.22%
363,002 $1.21 Million
Q1 2021

Apr 21, 2021
BUY
$3.77 - $6.05 $134,615 - $216,027
35,707 Added 16.67%
249,960 $1.34 Million
Q4 2020

Feb 12, 2021
BUY
$3.12 - $4.08 $25,019 - $32,717
8,019 Added 3.89%
214,253 $793,000
Q1 2020

May 13, 2020
SELL
$1.57 - $3.1 $31,400 - $62,000
-20,000 Reduced 8.84%
206,234 $324,000
Q3 2019

Nov 13, 2019
SELL
$2.58 - $3.97 $6,197 - $9,535
-2,402 Reduced 1.05%
226,234 $724,000
Q2 2019

Aug 14, 2019
BUY
$3.0 - $5.5 $35,772 - $65,582
11,924 Added 5.5%
228,636 $773,000
Q1 2019

May 15, 2019
BUY
$4.24 - $5.24 $663,369 - $819,824
156,455 Added 259.65%
216,712 $1.08 Million
Q4 2018

Feb 13, 2019
SELL
$3.95 - $6.55 $232,694 - $385,860
-58,910 Reduced 49.43%
60,257 $245,000
Q3 2018

Nov 13, 2018
BUY
$6.1 - $7.1 $217,709 - $253,399
35,690 Added 42.75%
119,167 $733,000
Q2 2018

Aug 13, 2018
BUY
$5.05 - $7.35 $198,970 - $289,590
39,400 Added 89.39%
83,477 $576,000
Q1 2018

May 14, 2018
BUY
$3.9 - $5.5 $253 - $357
65 Added 0.15%
44,077 $229,000
Q4 2017

Feb 14, 2018
BUY
$4.25 - $5.2 $6,103 - $7,467
1,436 Added 3.37%
44,012 $196,000
Q3 2017

Nov 14, 2017
BUY
$4.8 - $6.95 $111,868 - $161,976
23,306 Added 120.94%
42,576 $228,000
Q2 2017

Aug 14, 2017
BUY
N/A
19,270
19,270 $131,000

About MediWound Ltd.

MDWD Quotes by TradingView
  • Ticker MDWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,735,200
  • Market Cap $683M
  • Description
  • MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hosp...
More about MDWD
Track This Portfolio

Track Bokf, Na Portfolio

Follow Bokf, Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

News

Stay updated on Bokf, Na with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email